- Overview
- Alcohol Use Disorder
- Opioid Use Disorder
- Cannabis Use Disorder
- Prescription Drug Abuse
- Other Abused Substances
- Non-Substance Addictions
- View Full Guide
Advances in Treatment of Addiction
Skin Grafts
Psilocybin
Deep Brain Stimulation (DBS)
Methyllycaconitine (MLA)
Contingency Management Therapy
Personalized Treatments
Medication-Assisted Therapy (MAT)
Mindfulness
Photo Credits:
1) ISM / Jean-Claude RÉVY / Medical Images
2) 24K-Production / Getty Images
3) Pasieka / Science Source
4) George Lepp / Getty Images
5) LightFieldStudios / Getty Images
6) RichLegg / Getty Images
7) Ian Johnston / EyeEm / Getty Images
8) Westend61 / Getty Images
Sources:
Frontiers in Psychology: “Mindfulness training targets neurocognitive mechanisms of addiction at the attention-appraisal-emotion interface,” “Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials.”
Addiction Science and Clinical Practice: “Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research.”
FDA: “Information about Medication-Assisted Treatment (MAT).”
The American Journal of Psychiatry: “Personalizing the Treatment of Substance Use Disorders.”
The Psychiatrist: “Contingency management: what it is and why psychiatrists should want to use it.”
Neuropharmacology: “Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors.”
WVU Medicine: “WVU Rockefeller Neuroscience Institute first in U.S. to use deep brain stimulation to fight opioid addiction.”
NYU Langone Health: “Psychedelic Drug Therapy May Help Treat Alcohol Addiction.”
Department of Anesthesia and Critical Care: “DACC basic scientist Dr. Ming Xu launches start-up company to treat addiction.”
Current Drug Abuse Reviews: “Can MDMA Play a Role in the Treatment of Substance Abuse?”
Psychopharmacology: “Effects of methyllycaconitine (MLA), an α7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward.”